Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news

    pharma-news - Page 51

    Sanofi Allegra shows positive results in phase 3 study for allergic rhinitis

    Sanofi Allegra shows positive results in phase 3 study for allergic rhinitis

    Farhat Nasim18 Dec 2019 9:15 AM IST
    "The study demonstrated that Allegra/Telfast 180mg significantly decreased pollution- exacerbated AR symptoms by 21% (p=0.0148) in adult allergic...
    Bayer appeals to reverse USD 25 million Roundup verdict

    Bayer appeals to reverse USD 25 million Roundup verdict

    Medical Dialogues Bureau18 Dec 2019 9:00 AM IST
    In a filing in the U.S. Court of Appeals for the 9th Circuit dated Friday, Bayer said the verdict defied regulatory findings and sound science, adding...
    Indian trademark rights, brand for anti-diabetic drug Vildagliptin acquired by Cipla

    Indian trademark rights, brand for anti-diabetic drug Vildagliptin acquired by Cipla

    Medical Dialogues Bureau17 Dec 2019 2:14 PM IST
    Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus Metformin), the company...
    Indoco Remedies Goa plant gets GMP certificate from UK health regulator

    Indoco Remedies Goa plant gets GMP certificate from UK health regulator

    Medical Dialogues Bureau17 Dec 2019 9:30 AM IST
    This is an outcome of the last successful inspection conducted by UK Medicines and Healthcare Products Regulatory Agency (MHRA) from September 16-20...
    Pfizer, Astellas Pharma get USFDA nod for prostate cancer therapy Xtandi

    Pfizer, Astellas Pharma get USFDA nod for prostate cancer therapy Xtandi

    Medical Dialogues Bureau17 Dec 2019 9:15 AM IST
    Pfizer said Xtandi, in combination with an anti-hormone therapy, reduced the risk of cancer spreading or deaths by 61% in men with the disease,...
    Roche wins US antitrust nod for USD 4.3 billion deal to buy Spark Therapeutics

    Roche wins US antitrust nod for USD 4.3 billion deal to buy Spark Therapeutics

    Medical Dialogues Bureau17 Dec 2019 9:12 AM IST
    The FTC approved the deal, which was originally announced in February, without requiring any asset sales to ensure that the planned merger complies...
    Axsome Therapeutics depression drug AXS-05 meets goal in late-stage trial

    Axsome Therapeutics depression drug AXS-05 meets goal in late-stage trial

    Medical Dialogues Bureau17 Dec 2019 9:10 AM IST
    The trial results of Axsome Therpeutics' oral tablet, AXS-05 takes the company a step closer to acquiring a share of the multi-billion dollar market...
    Glenmark Baddi unit gets GMP certificate from State Institute for Drug Control

    Glenmark Baddi unit gets GMP certificate from State Institute for Drug Control

    Medical Dialogues Bureau16 Dec 2019 3:22 PM IST
    "The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of...
    Issue of Corruption in CDSCO raised in Parliament; Details

    Issue of Corruption in CDSCO raised in Parliament; Details

    Farhat Nasim16 Dec 2019 12:56 PM IST
    New Delhi: The sensitive issue of corruption plaguing every sector including the nodal drug regulatory body, Central Drugs Control Organisation...
    Amarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risks

    Amarin fish-oil drug Vascepa gets USFDA nod for cutting cardiac risks

    Medical Dialogues Bureau16 Dec 2019 11:48 AM IST
    Fish-oil based Vascepa sales brought Amarin just $287 million over 2019's first nine months, but analysts forecast the much-broader approval could...
    Horizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votes

    Horizon Therapeutics thyroid eye disease drug Teprotumumab gets USFDA panel votes

    Medical Dialogues Bureau16 Dec 2019 10:00 AM IST
    If approved, Horizon Therapeutics Plc's teprotumumab, a type of immunotherapy, is expected to become a standard of care for the vision-threatening...
    Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

    Abbott CEO Miles D White to step down in 2020, Robert B Ford to take over

    Medical Dialogues Bureau16 Dec 2019 9:30 AM IST
    Robert B Ford will become the 13th CEO of Abbott in its 131-year history, all having been appointed from within the Company, a testament to Abbott's...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok